NeuBase Therapeutics, Inc. Current Assets
NeuBase Therapeutics, Inc. had Current Assets of $13.35 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-11-09
- 2023-09-30: Assets, Current $13.35M.
- 2023-06-30: Assets, Current $15.52M.
- 2023-03-31: Assets, Current $14.21M.
- 2022-12-31: Assets, Current $17.97M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2023-09-30 | $13.35M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $15.52M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $14.21M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $17.97M 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $24.65M 10-QT · filed 2023-06-05 | |
| 2022-06-30 | $31.62M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $40.22M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $48.48M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $54.93M 10-K · filed 2022-12-21 | |
| 2021-06-30 | $60.22M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $24.94M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $28.82M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $32.81M 10-K · filed 2021-12-23 | |
| 2020-06-30 | $36.89M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $6.47M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $8.53M 10-Q · filed 2020-03-26 | |
| 2019-09-30 | $11.03M 10-K · filed 2020-12-23 | |
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.33M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.21M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $249.60K 10-K · filed 2020-01-10 | $4.00M 10-K · filed 2019-01-03 |
| 2018-06-30 | $4.85M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.84M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $8.82M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $13.02M 10-K · filed 2019-01-03 | |
| 2017-06-30 | $18.52M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $10.09M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $13.86M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $13.29M 10-K · filed 2017-12-15 | |
| 2016-06-30 | $17.86M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $22.34M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $27.10M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $29.04M 10-K · filed 2016-12-22 | |
| 2015-06-30 | $31.70M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $33.59M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $11.02M 10-Q · filed 2015-02-10 | |
| 2014-09-30 | $13.35M 10-K · filed 2015-12-14 | |
| 2014-06-30 | $15.10M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $3.71M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $4.04M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $5.17M 10-K · filed 2014-12-22 | |
| 2013-06-30 | $6.26M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $1.97M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $2.28M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $2.85M 10-K · filed 2013-12-27 | |
| 2012-06-30 | $1.91M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.22M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.34M 10-Q/A · filed 2012-02-14 | |
| 2011-09-30 | $691.75K 10-K · filed 2013-01-09 | |
| 2011-06-30 | $910.39K 10-Q · filed 2011-08-15 | |
| 2010-09-30 | $607.45K 10-K/A · filed 2012-01-18 |